Application analysis of two nucleic acid detection systems in blood detection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus
PeerJ · 2025
DOI: 10.7717/peerj.20365 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PeerJ, 2025. Verfasst von Tao Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Changzhou Blood Center, Changzhou, China. Hauptthemen laut MEDLINE: Hepacivirus, Hepatitis B virus, Hepatitis C, HIV. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changzhou city center blood station level project.
Abstract (Originalsprache)
Objective
This study aimed to compare the diagnostic efficacy between the Kehua and Roche nucleic acid testing (NAT) systems for detecting hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) in blood donation screening.
Methods
We analyzed retrospective data from 670,775 transient blood donation samples collected between 2016 and 2024. Key performance indicators (KPIs) included the types of reactive samples, effective split rate, effective reaction rate, single pool invalid number, batch invalid number, and pooling missing samples. Annual trends in cycle threshold (CT) value distributions and overall system performance were also evaluated.
Results
Among 419 reactive samples (Kehua: 202; Roche: 217), no significant differences were observed in the effective split rates ( P > 0.05) or overall specimen reaction rates ( P > 0.05) between the two systems. The HCV detection rate was significantly lower for the Kehua system ( P < 0.05), while the detection rates for HBV and HIV showed no significant inter-system differences ( P > 0.05). The separation efficiency of reactive pools varied significantly across different CT value ranges ( P < 0.05). The Kehua system demonstrated stable annual effective split and reaction rates ( P > 0.05), whereas the Roche system exhibited significant annual fluctuations in these metrics ( P < 0.05). The Kehua system had significantly fewer single pool invalid numbers and pooling omissions than the Roche system ( P < 0.05).
Conclusion
The Kehua and Roche NAT systems demonstrated comparable overall performance in blood screening, with Kehua proving non-inferior to Roche. Kehua’s advantages included fewer invalid tests and fewer pooling errors, which could reduce economic and time costs. The Roche system exhibited higher automation, supporting continuous batch processing. The observed CT value-dependent separation efficiency suggests potential for protocol optimization in detecting low viral load samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Changzhou Blood Center, Changzhou, China.
Förderung
- Changzhou city center blood station level project
Zitieren
APA
Wang, T., & Zhang, J. (2025). Application analysis of two nucleic acid detection systems in blood detection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus. PeerJ. https://doi.org/10.7717/peerj.20365
Vancouver
Wang T, Zhang J. Application analysis of two nucleic acid detection systems in blood detection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus. PeerJ. 2025. doi:10.7717/peerj.20365
BibTeX
@article{Wang2025,
author = {Wang, Tao and Zhang, Jianwei},
title = {Application analysis of two nucleic acid detection systems in blood detection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.20365}
}
EUVIMED